Morning Briefing
Summaries of health policy coverage from major news organizations
Single-Dose H1N1 Vaccine Wins Approval In China
The Chinese biopharmaceutical company Sinovac Biotech Ltd. on Monday announced its H1N1 (swine) flu vaccine won the approval of a panel of experts from China's State Food and Drug Administration, the Associated Press/Forbes reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.